• What are tissue engineering and regenerative medicine?
  • How do tissue engineering and regenerative medicine work?
  • How do tissue applied science and regenerative medicine fit in with electric current medical practices?
  • What are NIH-funded researchers developing in the areas of tissue technology and regenerative medicine?

What are tissue engineering science and regenerative medicine?

An image of a small human tissue engineered liver on the tip of a gloved hand
A mini bioengineered homo liver that can be implanted into mice. Source: Sangeeta Bhatia, MIT

Tissue technology evolved from the field of biomaterials development and refers to the do of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue technology is to assemble functional constructs that restore, maintain, or meliorate damaged tissues or whole organs. Artificial peel and cartilage are examples of engineered tissues that have been canonical past the FDA; still, currently they have limited apply in human patients.

Regenerative medicine is a broad field that includes tissue engineering but also incorporates research on self-healing – where the body uses its ain systems, sometimes with help foreign biological material to recreate cells and rebuild tissues and organs.  The terms "tissue engineering science" and "regenerative medicine" have become largely interchangeable, as the field hopes to focus on cures instead of treatments for complex, frequently chronic, diseases.

This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents, and tissue chips that can be used to examination the toxicity of an experimental medication.

What is Tissue Engineering?

How do tissue engineering and regenerative medicine work?

A baboon occyte surrounded by granulosa (cumulus) is cultured in a 3D alginate matrix
Source: Northwestern University

Cells are the edifice blocks of tissue, and tissues are the bones unit of measurement of function in the body. Generally, groups of cells make and secrete their own support structures, called extra-cellular matrix. This matrix, or scaffold, does more than but support the cells; it also acts equally a relay station for various signaling molecules. Thus, cells receive messages from many sources that become bachelor from the local environment. Each signal tin start a chain of responses that determine what happens to the jail cell. By understanding how individual cells answer to signals, interact with their environment, and organize into tissues and organisms, researchers have been able to manipulate these processes to mend damaged tissues or even create new ones.

The process often begins with building a scaffold from a wide set up of possible sources, from proteins to plastics. One time scaffolds are created, cells with or without a "cocktail" of growth factors can be introduced. If the surround is right, a tissue develops.  In some cases, the cells, scaffolds, and growth factors are all mixed together at once, allowing the tissue to "self-assemble."

Another method to create new tissue uses an existing scaffold. The cells of a donor organ are stripped and the remaining collagen scaffold is used to grow new tissue. This process has been used to bioengineer heart, liver, lung, and kidney tissue. This arroyo holds keen hope for using scaffolding from man tissue discarded during surgery and combining information technology with a patient's ain cells to brand customized organs that would not be rejected by the allowed organization.

How exercise tissue technology and regenerative medicine fit in with current medical practices?

An image of two gloved hands stretching a blueish material with white lines all over it
A biomaterial made from pigs' intestines which can exist used to heal wounds in humans. When moistened, the fabric, which is called Sister, is flexible and easy to handle.
Source: Stephen Badylak, Academy of Pittsburgh.

Currently, tissue engineering science plays a relatively small-scale role in patient treatment. Supplemental bladders, minor arteries, skin grafts, cartilage, and even a full trachea take been implanted in patients, simply the procedures are nonetheless experimental and very costly. While more complex organ tissues like eye, lung, and liver tissue accept been successfully recreated in the lab, they are a long way from being fully reproducible and ready to implant into a patient. These tissues, however, tin be quite useful in research, especially in drug development. Using functioning human tissue to help screen medication candidates could speed up development and provide central tools for facilitating personalized medicine while saving money and reducing the number of animals used for research.

What are NIH-funded researchers developing in the areas of tissue technology and regenerative medicine?

Research supported by NIBIB includes development of new scaffold materials and new tools to fabricate, epitome, monitor, and preserve engineered tissues. Some examples of research in this area are described below.

  • Controlling stem cells through their environment:
    For many years, scientists have searched for ways to control how stems cells develop into other cell types, in the hopes of creating new therapies. Two NIBIB researchers accept grown pluripotent cells—stem cells that accept the ability to turn into any kind of cell—in dissimilar types of defined spaces and establish that this confinement triggered very specific gene networks that determined the ultimate fate for the cells. Most other medical inquiry on pluripotent stalk cells has focused on modifying the combination of growth solutions in which the cells are placed. The discovery that there is a biomechanical element to decision-making how stalk cells transform into other cell types is an of import piece of the puzzle as scientists try to harness stems cells for medical uses.

Thumbnail

Man Livers in Mice Assistance Therapeutics
  • Implanting human livers in mice:
    NIBIB-funded researchers have engineered human liver tissue that can be implanted in a mouse. The mouse retains its ain liver as well, and therefore its normal part-but the added piece of engineered human liver can metabolize drugs in the same way humans do. This allows researchers to test susceptibility to toxicity and to demonstrate species-specific responses that typically practice not testify upwards until clinical trials. Using engineered human tissue in this style could cut down on the time and toll of producing new drugs, as well equally allow for critical examinations of drug-drug interactions within a human-like system.
  • Technology mature bone stem cells:
    Researchers funded by NIBIB completed the first published study that has been able to take stem cells all the fashion from their pluripotent state to mature os grafts that could potentially be transplanted into a patient. Previously, investigators could only differentiate the cells to a primitive version of the tissue which was not fully functional. Additionally, the study establish that when the bone was implanted in immunodeficient mice there were no abnormal growths afterwards—a problem that often occurs after implanting stem cells or os scaffolds alone.
  • Using lattices to help engineered tissue survive:
    Currently, engineered tissues that are larger than 200 microns (about twice the width of a homo pilus) in any dimension cannot survive considering they exercise non have vascular networks (veins or arteries). Tissues need a good "plumbing system"—a way to bring nutrients to the cells and comport abroad the waste—and without a blood supply or similar mechanism, the cells quickly die. Ideally, scientists would like to be able to create engineered tissue with this plumbing system already built in.  1 NIBIB funded researcher is working on a very simple and easily reproducible system to solve this problem: a modified ink-jet printer that lays down a lattice made of a saccharide solution. This solution hardens and the engineered tissue (in a gel course) surrounds the lattice. Later, blood is added which easily dissolves the sugar lattice, leaving pre-formed channels to human action every bit claret vessels.
3 MRI images of a knee before a season of NBA basketball, 3 post-season
Source: Garry Gold
  • New promise for the bum knee:
    Until at present, cartilage has been very difficult, if not impossible, to repair due to the fact that cartilage lacks a blood supply to promote regeneration. There has been a 50% long-term success charge per unit using microfracture surgery in young adults suffering from sports injuries, and little to no success in patients with widespread cartilage degeneration such as osteoarthritis. An NIBIB-funded tissue engineer has developed a biological gel that can be injected into a cartilage defect post-obit microfracture surgery to create an environment that facilitates regeneration. However, in order for this gel to stay in place within the knee, researchers besides adult a new biological adhesive that is able to bond to both the gel as well as the damaged cartilage in the knee, keeping the newly regrown cartilage in place. The gel/adhesive combo was successful in regenerating cartilage tissue following surgery in a contempo clinical trial of fifteen patients, all of whom reported decreased hurting at six months post-surgery. In contrast, the majority of microfracture patients, after an initial decrease in pain, returned to their original hurting level within six months. This researcher worked in collaboration with some other NIBIB grantee to prototype the patients who had undergone surgery enabling scientists to combine new, not-invasive methods to run across the evolving results in existent-time.
  • Regenerating a new kidney:
    The ability to regenerate a new kidney from a patient'due south own cells would provide major relief for the hundreds of thousands of patients suffering from kidney disease. Experimenting on rat, sus scrofa and human kidney cells, NIDDK supported researchers broke new basis on this front by first stripping cells from a donor organ and using the remaining collagen scaffold to aid guide the growth of new tissue. To regenerate viable kidney tissue, researchers seeded the kidney scaffolds with epithelial and endothelial cells. The resulting organ tissue was able to articulate metabolites, reabsorb nutrients, and produce urine both in vitro and in vivo in rats. This process was previously used to bioengineer eye, liver, and lung tissue. The creation of transplantable tissue to permanently replace kidney function is a leap frontward in overcoming the bug of donor organ shortages and the morbidity associated with immunosuppression in organ transplants.

Explore More

There is so much more to explore at NIBIB.

Health Topics

Enquiry Topics